Amgen (AMGN) Gross Margin (2009 - 2026)

Amgen (AMGN) has reported Gross Margin for 18 consecutive years, with 68.16% the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Margin rose 458.0% year-over-year to 68.16%; the TTM figure through Mar 2026 stood at 104.96% (up 3247.0% YoY), while the FY2025 annual figure was 96.43%, up 3490.0% from the prior year.
• Gross Margin came in at 68.16% for Q1 2026 at Amgen, down from 178.54% in the prior quarter.
• The five-year high for Gross Margin was 178.54% in Q4 2025, with the low at 280.61% in Q4 2022.
• Average Gross Margin over 5 years is 60.67%, with a median of 73.84% recorded in 2023.
• Across the five-year window, Gross Margin plunged 44696 bps in 2022 and soared 34264 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 280.61% in 2022, then surged by 122 bps to 62.03% in 2023, then climbed by 6 bps to 65.75% in 2024, then surged by 172 bps to 178.54% in 2025, then slumped by 62 bps to 68.16% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 68.16%, 178.54%, and 67.75% for Q1 2026, Q4 2025, and Q3 2025 respectively.